HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yasui, K. Articles by Nakano, T. Search for Related Content PubMed PubMed Citation Articles by Yasui, K. Articles by Nakano, T.

Differences Between Peripheral Blood and Cord Blood in the Kinetics of Lineage-Restricted Hematopoietic Cells: Implications for Delayed Platelet Recovery Following Cord Blood Transplantation

Osaka Red Cross Blood Center, Osaka, Japan; Department of Molecular Cell Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

Key Words. AC133 antigen • CD34 antigen • Cord blood • Peripheral blood

Correspondence: Kayoko Matsumoto, Ph.D., Osaka Red Cross Blood Center, Morinomiya 2-4-43, Johtoh-ku, Osaka 536-8505, Japan. Telephone: 81-6-6962-7056; Fax: 81-6-6962-7652; e-mail: kayokoma{at}a1.mbn.or.jp

Cord blood (CB) cells are a useful source of hematopoietic cells for transplantation. The hematopoietic activities of CB cells are different from those of bone marrow and peripheral blood (PB) cells. Platelet recovery is significantly slower after transplantation with CB cells than with cells from other sources. However, the cellular mechanisms underlying these differences have not been elucidated. We compared the surface marker expression profiles of PB and CB hematopoietic cells. We focused on two surface markers of hematopoietic cell immaturity, i.e., CD34 and AC133. In addition to differences in surface marker expression, the PB and CB cells showed nonidentical differentiation pathways from AC133⁺CD34⁺ (immature) hematopoietic cells to terminally differentiated cells. The majority of the AC133⁺CD34⁺ PB cells initially lost AC133 expression and eventually became AC133^-CD34^- cells. In contrast, the AC133⁺CD34⁺ CB cells did not go through the intermediate AC133^-CD34⁺ stage and lost both markers simultaneously. Meanwhile, the vast majority of megakaryocyte progenitors were of the AC133^-CD34⁺ phenotype. We conclude that the delayed recovery of platelets after CB transplantation is due to both subpopulation distribution and the process of differentiation from AC133⁺CD34⁺ cells.

This article has been cited by other articles:

				E. Goussetis, M. Theodosaki, G. Paterakis, C. Tsecoura, and S. Graphakos In Vitro Identification of a Cord Blood CD133+CD34-Lin+ Cell Subset that Gives Rise to Myeloid Dendritic Precursors Stem Cells, April 1, 2006; 24(4): 1137 - 1140. [Full Text] [PDF]